Benndorf R, Hayess K, Stahl J, Bielka H
Max-Delbrück-Centrum für Molekulare Medizin, Berlin-Buch, Germany.
Biochim Biophys Acta. 1992 Aug 12;1136(2):203-7. doi: 10.1016/0167-4889(92)90258-d.
The small heat-shock protein hsp25 of the Ehrlich ascites tumor exists in one non-phosphorylated (hsp25/1) and two phosphorylated (hsp25/2, hsp25/3) isoforms. In stationary phase tumor cells, a protein kinase activity was detected which phosphorylates hsp25/1, resulting in the formation of several phosphorylated hsp25 isoforms, including those occurring naturally in the tumor. Cell-free phosphorylation of hsp25 required Mg2+ and ATP and was independent of Ca2+, phosphatidylserine, cAMP and cGMP. Polymyxin B inhibited, specifically, hsp25 phosphorylation, whereas trifluoperazine, staurosporine and the protein inhibitor of protein kinase A had no effect. In its properties, the hsp25 phosphorylating kinase differs from other common kinases such as protein kinases A and C, calcium/calmodulin-dependent kinases, and the ribosomal protein S6 kinase.
艾氏腹水瘤的小分子热休克蛋白hsp25以一种非磷酸化形式(hsp25/1)和两种磷酸化形式(hsp25/2、hsp25/3)存在。在静止期肿瘤细胞中,检测到一种蛋白激酶活性,它可使hsp25/1磷酸化,导致形成几种磷酸化的hsp25异构体,包括肿瘤中天然存在的那些异构体。hsp25的无细胞磷酸化需要Mg2+和ATP,且不依赖于Ca2+、磷脂酰丝氨酸、cAMP和cGMP。多粘菌素B特异性抑制hsp25磷酸化,而三氟拉嗪、星形孢菌素和蛋白激酶A的蛋白抑制剂则无作用。就其性质而言,hsp25磷酸化激酶不同于其他常见激酶,如蛋白激酶A和C、钙/钙调蛋白依赖性激酶以及核糖体蛋白S6激酶。